Nathaniel Brooks Horwitz

 

Nathaniel Brooks Horwitz is a venture capitalist in the biotechnology sector. He was the founder and chief executive of Nivien Therapeutics, a startup company that developed an experimental drug for pancreatic cancer. His writing has been published by The Washington Post, The New York Times, The Boston Globe, The Atlantic, The Daily Beast and others. He graduated from Harvard with a degree in molecular biology.

Leave a reply

Theme developed by TouchSize - Premium WordPress Themes and Websites